Install
Medical news, education and information for physicians and health care professionals, presented by specialty and topic. From Healio and the Wyanoke Group.
- 299articles · 30d
- 1+ day agolatest article
- Aug 14, 2026earliest in window
- 75%with images
- 84avg words
- Medical 294
- Health 292
- Health & Wellness 272
- Beauty & Fitness 6
- Food & Drink 4
- Law & Government 3
- Science & Technology 3
- Sensitive Subjects 3
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Inflammatory bowel disease events rare with IL-17s for hidradenitis suppurativa
2+ day, 8+ hour ago (52+ words) Interleukin-17 therapy for hidradenitis suppurativa was not associated with an increased risk for inflammatory bowel disease, according to a study published in JAMA Dermatology. Of the 2,572 patients with HS who were treated with an IL-17 inhibitor across 10 randomized clinical trials, only…...
NCI funding for obesity and cancer studies increase over last 10 years
1+ week, 4+ day ago (143+ words) NCI-supported obesity and cancer research has steadily increased over the past decade.A portfolio analysis revealed NCI funded nearly 350 new grants between 2015 and 2022, most of which focused on mechanisms and/or behaviors....
Variation in antibody response evident ‘long before symptoms’ of IBD develop
2+ week, 4+ day ago (290+ words) Serological profiling detected distinct immune-response changes long before symptoms emerged among patients who developed inflammatory bowel disease compared with healthy controls, according to a case-control study published in Gut.Differences in antibody response were identified up to 10 years before diagnosis,…...
Anti-TL1A duvakitug demonstrates ‘robust’ response in Crohn’s disease, ulcerative colitis
3+ week, 4+ day ago (604+ words) An investigational anti-TL1A monoclonal antibody achieved “clinically meaningful” outcomes compared with placebo in patients with inflammatory bowel disease, according to results of the RELIEVE UCCD trial.Duvakitug (TEV-48574; Teva Pharmaceuticals, Sanofi) demonstrated efficacy in clinical remission at week…...